Lv4
705 积分 2021-06-04 加入
Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist
4天前
已完结
Advances in oral peptide therapeutics
4天前
已完结
Oral Peptide Delivery Reimagined: Molecular Barriers, Formulation Strategies, and the Rise of Computational Design
4天前
已完结
Harnessing the apical sodium-dependent bile acid transporter for enhanced oral delivery of peptide drugs: mechanisms, strategies, and therapeutic potential
5天前
已完结
Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning
5天前
已完结
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation
5天前
已完结
Synthesis and pharmacological action of TRH analog peptide(Taltirelin)
6天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
16天前
已完结
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
16天前
已完结
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
16天前
已完结
皖公网安备34019202002308
